Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dapagliflozin in Peritoneal Dialysis (PRESERVE)
NCT05250752Phase 2Unknown
- Sponsor
- Holbæk Hospital
- Start
- Nov 2021
- Primary completion
- Feb 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of dapagliflozin in peritoneal dialysis (PD), sponsored by Holbæk Hospital. Status: unknown.
02
Drugs
dapagliflozin
03
Conditions
peritoneal dialysis (PD)
Beyond the preview
Go deeper on NCT05250752.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05250752.